Sanigen Co

Sanigen Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Sanigen Co (188260.KQ) as of Oct 26, 2026 is -3.20. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -1.47 — a change of 117.58% (lower).

EV/FCF

-3.20

YoY

117.58%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Sanigen Co is 2025 -3.20 . EV/FCF (Enterprise Value to Free Cash Flow) of Sanigen Co was 2024 -1.47 . It decreases by 117.58% lower compared to the previous year.

The Sanigen Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
-15.89 KRW
Jan 1, 2020
-11.74 KRW
Jan 1, 2021
-4.23 KRW
Jan 1, 2022
-1.56 KRW
Jan 1, 2023
-0.92 KRW
Jan 1, 2024
-1.47 KRW
Jan 1, 2025
-3.20 KRW
The Sanigen Co EV/FCF history
YEAREV/FCFYoY
-3.20+117.58%
-1.47+60.42%
-0.92-41.17%
-1.56-63.17%
-4.23-63.97%
-11.74-26.15%
-15.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sanigen Co Stock analysis

What does Sanigen Co do? Sanigen Co Ltd generates revenue through the manufacturing and sale of food safety diagnostic products, utilizing advanced molecular diagnostic technologies including polymerase chain reaction (PCR) and next-generation sequencing (NGS). The company provides food microbial genome analysis services as part of its offerings. Its primary customers are entities requiring food safety testing, such as food manufacturers and regulatory agencies. The firm operates within the Health Care Equipment & Supplies industry, focusing on diagnostic solutions for food safety. Sanigen Co Ltd's product portfolio includes diagnostic products developed using PCR and NGS technologies, which are sold to clients in the food safety sector. The company's services encompass microbial genome analysis, targeting clients needing detailed food safety assessments. The business model centers on delivering diagnostic tools and services that ensure food safety through advanced molecular technologies. The company's revenue streams are derived from the sale of diagnostic products and the provision of microbial genome analysis services. These offerings are tailored to meet the needs of food safety testing in the industry. Sanigen Co Ltd's focus on molecular diagnostic technologies positions it as a provider of specialized solutions within the health care equipment and supplies market. Sanigen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanigen Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Sanigen Co is -3.20 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Sanigen Co changed from -1.47 to -3.20, representing a 117.58% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Sanigen Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Sanigen Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Sanigen Co

All Key Metrics — Sanigen Co